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A B S T R A C T
Background: Few studies have investigated congenital anomalies in relation to municipal waste incinerators
(MWIs) and results are inconclusive.
Objectives: To conduct a national investigation into the risk of congenital anomalies in babies born to mothers
living within 10 km of an MWI associated with: i) modelled concentrations of PM10 as a proxy for MWI emissions
more generally and; ii) proximity of residential postcode to nearest MWI, in areas in England and Scotland that
are covered by a congenital anomaly register.
Methods: Retrospective population-based cohort study within 10 km of 10 MWIs in England and Scotland op-
erating between 2003 and 2010. Exposure was proximity to MWI and log of daily mean modelled ground-level
particulate matter ≤10 μm diameter (PM10) concentrations.
Results: Analysis included 219,486 births, stillbirths and terminations of pregnancy for fetal anomaly of which
5154 were cases of congenital anomalies. Fully adjusted odds ratio (OR) per doubling in PM10 was: 1·00 (95% CI
0·98–1·02) for all congenital anomalies; 0·99 (0·97–1·01) for all congenital anomalies excluding chromosomal
anomalies. For every 1 km closer to an MWI adjusted OR was: 1·02 (1·00–1·04) for all congenital anomalies
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combined; 1·02 (1·00–1·04) for all congenital anomalies excluding chromosomal anomalies; and, for specific
anomaly groups, 1·04 (1·01–1·08) for congenital heart defect sand 1·07 (1·02–1·12) for genital anomalies.
Discussion: We found no increased risk of congenital anomalies in relation to modelled PM10 emissions, but there
were small excess risks associated with congenital heart defects and genital anomalies in proximity to MWIs.
These latter findings may well reflect incomplete control for confounding, but a possible causal effect cannot be
excluded.
1. Introduction
Over the last 20 years, the move to reduce landfill waste has driven
an increase in waste incineration in the European Union (EU) (Vehlow
et al., 2007). Municipal waste incinerators (MWIs) burn non-hazardous
waste mostly from households and commercial establishments, at high
temperatures. Emissions from MWIs are currently regulated under the
EU Industrial Emissions Directive (IED) (2010/75/EU) (European
Union, 2010), which incorporated the Waste Incineration Directive
(EU-WID) (2000/76/EC) implemented in Great Britain (GB) on 28
December 2002 and 28 December 2005 for new and existing MWIs
respectively. Emissions include particulates, sulphur dioxide (SO2), ni-
trogen oxides (NOX), heavy metals, polychlorinated dibenzo-p-dioxins
and furans (PCDD/Fs), polycyclic aromatic hydrocarbon (PAH) and
polychlorinated biphenyls (PCBs). Limits for MWI emissions are set by
the EU under the IED. However, there remains public concern and
scientific uncertainty about possible health effects on the population
exposed to emissions from MWIs (Health Protection Agency, 2009).
In a recent systematic review (subsequently updated for this re-
search) of the association between municipal waste incineration and
birth outcomes, results were inconsistent and inconclusive (Ashworth
et al., 2014; Candela et al., 2013; Candela et al., 2015; Santoro et al.,
2016). There are few investigations of municipal waste incineration and
health specifically focussed on congenital anomalies (Cordier et al.,
2004; Cordier et al., 2010; Cresswell et al., 2003; Dummer et al., 2003;
Jansson and Voog, 1988; Tango et al., 2004; ten Tusscher et al., 2000;
Vinceti et al., 2008; Vinceti et al., 2009; Vinceti et al., 2018). The start
dates of all these studies pre-date the implementation of the Industrial
Emissions Directive for existing MWIs (28 December 2005). Five se-
parate studies have found some increased risks with specific congenital
anomaly groups, and include facial clefts (Cordier et al., 2004; ten
Tusscher et al., 2000), renal and urological anomalies (Cordier et al.,
2004; Cordier et al., 2010) neural tube defects, spina bifida and lethal
congenital heart defects (CHDs) (Dummer et al., 2003) and deaths due
to all congenital anomalies combined (Tango et al., 2004). These in-
consistent findings may reflect chance findings related to small num-
bers of cases in some studies, different types of MWIs with differing
exposure profiles, varying study designs and limitations in exposure
assessment.
The study aim was to conduct a national investigation into the risk
of congenital anomalies in babies born to mothers living within 10 km
of an MWI associated with: i) modelled concentrations of PM10 as a
proxy for MWI emissions more generally and; ii) proximity of re-
sidential postcode to nearest MWI, in areas in England and Scotland
that are covered by a congenital anomaly register.
2. Methods
2.1. Study area
The study area was defined as all centroids of postcodes (re-
presenting on average 12 households) occurring within a 10 km radius
of at least one MWI in a region of England or Scotland covered by a
participating Regional Congenital Anomaly Register (RCAR) during the
study period 1 April 2003 to 31 December 2010 (the RCAR for Wales
did not take part in this study). Fig. 1 shows the 11 MWIs and RCARs
eligible for inclusion in the study, covering approximately 24·5 million
of the population of England and Scotland. Grundon MWI commenced
operation in February 2010 so there were too few congenital anomalies
during the study period to be included.
2.2. Outcomes
The primary outcome groups analysed were:
• One or more congenital anomalies (International Classification of
Diseases tenth revision (ICD10) codes: Q00 – Q99, D215, D821,
D1810, P350, P351, P371)• Specific congenital anomaly groups based on previous evidence
(nervous System (Q00-Q07 excl. Q0461, Q0782), congenital heart
defects (CHDs) (Q20-Q26 excluding Q2111, Q2541, Q261, Q250
(<37weeks gestation), Q256 (<37weeks gestation)), abdominal
wall defects (Q792, Q793, Q795, Q7950, Q7951, Q7959), orofacial
clefts (Q35-Q37), limb defects (Q65-Q74 excluding Q653-Q656,
Q662-Q678, Q680–685, Q7400), digestive system (Q790, Q38-Q45
excluding Q381, Q382, Q3850, Q400, Q401, Q4021, Q430, Q4320,
Q4381, Q4382), urinary (Q60-Q64, Q794 excluding Q610, Q627,
Q633), genital organs (Q50-Q52, Q54-Q56 excluding Q523, Q525,
Q527, Q5520, Q5521))
Secondary outcome groups analysed were:
• One or more congenital anomalies excluding chromosomal con-
genital anomalies (Q90-Q99).• Specific congenital anomaly sub-groups (neural tube defects (Q00,
Q01, Q05), severe CHDs (Q200-Q204, Q212, Q213, Q220, Q224
-Q226, Q230, Q232-Q234, Q251, Q252, Q262), gastroschisis
(Q793), cleft palate (Q35), cleft lip with or without cleft palate
(Q36, Q37), limb reduction defects (Q71-Q73), oesophageal atresia
(Q390, Q391, Q3911), anomalies of the renal system (Q60-Q61
excluding Q610), obstructive defects of renal pelvis (Q62, Q64 ex-
cluding Q627), hypospadias (Q54)).
Descriptions of ICD10 codes are listed in Table S1. Congenital
anomalies data were provided by the participating RCARs, five in
England (Congenital Anomaly Register for Oxfordshire, Berkshire and
Buckinghamshire (CAROBB); East Midlands & South Yorkshire
Congenital Anomaly Register (EMSYCAR); Northern Congenital
Abnormality Survey (NorCAS); South West Congenital Anomaly
Register (SWCAR); Wessex Antenatally Detected Anomalies Register
(WANDA)), and data for the whole of Scotland, collated from multiple
sources linking Scottish Stillbirth and Infant Death Survey (SSBID),
Scottish Birth Record (SBR), SMR11 (historic version of SBR), SMR01
(hospital activity) and National Records Scotland Still Birth & Infant
Deaths.
Denominator data for England and Scotland were obtained from the
Office for National Statistics (ONS) Births and Stillbirths register and
the Information Services Division (ISD) Scotland Scottish Birth Record
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Fig. 1. Map of England, Wales and Scotland showing the regional congenital anomaly register (RCAR) areas and the locations of the 10municipal waste incinerators
(MWIs) in the study. The Grundon (Lakeside) MWI commenced operation in February 2010; there were too few congenital anomalies during the study period to
include this site. All MWIs in the study operate to the European Union Waste Incinerator Directive (EU-WID).
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respectively. Data about terminations of pregnancy for fetal anomaly
(TOPFAs) for England were provided by the Department of Health (now
called Department of Health and Social Care). Ethnicity information
was obtained by linking the National Health Service (NHS) Numbers for
Babies (NN4B) births data to the ONS data for 2006 to 2010 (the years
available).
For data governance reasons, we were unable to link records in the
English RCARs with other datasets; consequently all live-born babies
affected by a congenital anomaly in England (estimated to be 2·3% by
the British Isles Network of Congenital Anomaly Registers (BINOCAR))
are duplicated in the denominator dataset. Data from Scotland were
provided in a single dataset, avoiding duplicates. Fig. 2 summarises the
datasets involved and how they were combined.
The English RCAR data are supplied to the European surveillance of
congenital anomalies (EUROCAT) which requires the exclusion of
minor anomalies. In Scotland the data are not supplied to EUROCAT
and, due to a technical issue, the Scottish congenital anomaly data
supplied to us did not include the 5th character of the ICD10 code,
meaning it was not possible to be certain if all cases can be correctly
identified as minor or major. No data on TOPFAs are available for
Scotland resulting in a potential underestimation of congenital anomaly
rates in Scotland.
Harmonising the English and Scottish data involved:
• Removing cases of congenital anomalies from the Scottish data that
could be identified as minor based on the EUROCAT codes.• Identifying inconsistencies of rates of certain anomalies between the
English and Scottish data, e.g. excluding 70 cases of ICD10 Q828
(other specified congenital malformations of skin) in Scotland as
these were likely to be minor. Higher rates for certain ICDs in
England compared to Scotland could be explained by the absence of
TOPFA and prenatal data for Scotland.
Cases with multiple congenital anomalies were counted once for
each case when analysing all congenital anomalies combined and all
congenital anomalies excluding chromosomal, and under each outcome
when analysing specific congenital anomalies groups and sub-groups.
So an individual with multiple congenital anomalies may appear more
than once when analysing separate congenital anomalies groups and
sub-groups. When excluding chromosomal anomalies, it was assumed
that the presence of a chromosomal anomaly was the underlying cause
of any additional (non-chromosomal) anomalies (Garne et al., 2011).
All birth records (births, stillbirths and TOPFAs) in the study area
were included if conception was after 1 April 2003 and birth or
Fig. 2. Schematic of the health datasets used for the congenital anomalies study.
* Scottish congenital anomalies data created by linking Scottish Stillbirth and Infant Death Survey (SSBID), Scottish Birth Record (SBR), General/Acute Inpatient and
Day Case dataset (SMR01) and National Records of Scotland Still Birth & Infant Deaths.
# Birth records meet the study criteria if 91 day pre-pregnancy period starts after the MWI commenced operation.
† The number of cases (5154) shown in Fig. 2 indicates births with at least one major congenital anomaly.
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termination was before 31 December 2010 and the mother's residence
at birth or termination was within 10 km of an operational MWI.
2.3. Exposure assessment
We used two metrics to represent ‘exposure’ to MWI emissions: i)
dispersion modelling using ADMS-Urban software from Cambridge
Environmental Research Consultants (CERC), taking account of me-
teorological factors including wind direction – to estimate daily mean
ground-level PM10 concentrations from MWI emissions at each post-
code centroid within 10 km of the included MWIs (as a proxy for MWI
emissions more generally), as previously described by Douglas et al.
(2017) and references therein; ii) proximity to nearest MWI – calculated
as a continuous measure of straight line distance of the MWI co-
ordinates to the postcode centroid of mother's residence at time of birth.
Most congenital anomalies are known to occur in the first trimester
of pregnancy (Rankin et al., 2009); hence we defined the critical
window of exposure for the dispersion modelling as the 91 days prior to
calculated/estimated date of conception (to cover the sperm re-
generation cycle) plus the first trimester of pregnancy (with exposure
represented by mean PM10 concentration over the period). Two sepa-
rate sensitivity analyses were run using just the 91 days prior to cal-
culated/estimated date of conception and just the first trimester as
exposure periods (see supplemental table S5 for details of sensitivity
analyses). For births after the start of 2006, the gestational age at birth
was available allowing us to estimate the conception date by sub-
tracting the gestational age from the date of birth. For births prior to
2006, the pregnancy was assumed to be 279 days which was the median
pregnancy duration for the births in our dataset 2006–2010. Exposure
could not be estimated for all individuals as not all MWIs in the study
were operational by the start of 2003; some MWIs had periods of non-
operation and data from SWCAR were only available from the start of
2005 (see Douglas et al. (2017) for details of MWI operating dates). As
the distribution of the modelled PM10 concentrations was heavily right-
skewed, PM10 concentrations were log transformed prior to analysis.
We used mother's residential postcode at birth for the distance-based
analyses.
2.4. Potential confounders
Potential confounders were selected a priori to reflect factors that
have previously been associated with risk of congenital anomalies (see
supplemental table S2). Individual level confounders were maternal age
(categories in years: <20; 20–29; 30–39; >40) and year of birth or
termination. Area-level confounders were deprivation by fifths of the
Carstairs deprivation index (comprising lack of car ownership, low
occupational social class, overcrowded households and male un-
employment at the census output area (COA) level – comprising 40–250
households) and area-level ethnicity (% of white women aged 16–49 at
the middle layer super output area (MSOA) level – 2000–6000 house-
holds). In addition, major road density (length of motorways, A-roads
and B-roads) within 10 km of the MWI, major road density within
250m of mother's postcode and other sources of emissions were used as
proxies for background air pollution. The data for ‘other sources of
emissions’ were based on the total number of industries in operation
within 10 km of each MWI for each year of operation, obtained from the
Environment Agency in England and the Scottish Pollutant Release
Inventory (Table S3).
Sensitivity analyses additionally adjusted for: sex; individual level
ethnicity (only available for England after 2006); tobacco sales (not
available in Scotland) at COA level, as a proxy for smoking; and mul-
tiple births (see Supplemental Material, Table S5 for details of sensi-
tivity analyses).
2.5. Statistical analysis
We used logistic regression to examine associations between each
measure of exposure and outcome, adjusting for available potential
confounders listed above. We did not have information on MWI feed-
stocks; these were likely to be heterogeneous with relative pollutant
concentrations emitted varying between MWIs; we therefore included a
random slope for the PM10 exposure variable in all models. We also
included a random intercept for MWI to allow for possible unmeasured
confounding effects e.g. other local sources of pollution for which only
area level proxies were available. As PM10 data were log transformed,
odds ratios (ORs) indicate the risk associated with a multiplicative in-
crease in PM10 concentrations; here we report the risk associated with a
doubling (100% increase) in MWI emission-related PM10, i.e. an OR of
1·1 would indicate a 10% increase in risk each time the PM10 con-
centration is doubled. Our primary analysis was fully adjusted logistic
regression with a random intercept for MWI and random slope for the
PM10 exposure variable.
To evaluate associations of MWI emissions and proximity, we pre-
sent odds ratios and 95% confidence intervals. In view of the large
number of analyses, we also present p-values adjusted for multiple
testing using the procedure proposed by Simes which is recommended
when several tests may be highly correlated (Simes, 1986). All analyses
were conducted in R version 3.2.2 (available from: https://www.R-
project.org) (R Core Team, 2015). See Supplemental Material for details
of regression models.
3. Results
After exclusions (Fig. 2) we included 219,486 births, stillbirths and
terminations of pregnancy for fetal anomaly of which 5154 were cases
of congenital anomalies (Table 1). Mean modelled PM10 concentrations
for 91 day pre-pregnancy period and first trimester was 0·64 10−3 μg/
m3 [IQR 0·14–0·76] and 0·67 10−3 μg/m3 [IQR 0·14–0·80] for the births
and congenital anomaly cases respectively (Table 2). Mean distance
from postcode of maternal residence to nearest MWI was 5·44 km [IQR
3·57–7·23] and 5·28 km [IQR 3·45–7·03] for births and cases respec-
tively. No births were within 10 km of more than one MWI (Fig. 1).
Numbers of congenital anomaly cases by ICD group and sub-group are
listed in table S10.
There was limited correlation between proximity to nearest MWI
and modelled PM10, percent of non-white women and deprivation
(Pearson correlation= 0·31 (95% CI 0·30–0·31) for PM10, 0·45
(0·45–0·46) ethnicity and 0·22 (0·22–0·22) deprivation) (table S4).
We found no associations between modelled PM10 concentrations
from MWIs and all congenital anomalies when fully adjusted for con-
founders (Table 3a, Table S11a). However, with proximity to nearest
MWI, there was a small (2%) excess risk of all congenital anomalies
combined for each kilometre closer to the MWI [OR 1·02; 95% CI
1·00–1·04] (Table 3b, Table S11b).
There were no significant associations between modelled PM10 and
any of the individual congenital anomalies groups and sub-groups after
fully adjusting for confounders (Table 4a). Associations with proximity
to nearest MWI were found for CHDs [OR 1·04; 95% CI 1·01–1·08] and
genital anomalies [OR 1·07; 95% CI 1·02–1·12] (Table 4b) which make
up the majority of the excess risk found when analysing all congenital
anomalies. For hypospadias, which make up 85·6% of genital anoma-
lies, there was a 7% excess risk for each kilometre closer to the MWI
[OR 1·07; 95% CI 1·01–1·12].
After Simes procedure adjustment for multiple testing, p-values
were robust to adjustment for genital anomalies but not for CHDs (table
S12). Findings from sensitivity analyses showed no material difference
to those from main models (table S6), other than addition of individual
ethnicity as a confounder; this is likely due to bias introduced by the
difference in completeness of individual ethnicity data between nu-
merator (38·3%) and denominator (73·8%) datasets. Additionally, the
B. Parkes, et al. Environment International 134 (2020) 104845
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analysis that excluded area-level covariates (deprivation and ethnicity)
showed a slightly larger association between all congenital anomalies
and proximity to nearest MWI [OR 1·03; 95% CI 1·01–1·04]. The ma-
jority of exclusions (3.3%) were due to incomplete exposure data
(Fig. 2), because birth events were excluded if >10% of ADMS data was
missing for the exposure period. To investigate the effect of this we ran
2 sensitivity analyses with exclusion criteria of 5% and 15% as the cut-
off points for missing ADMS data. The results were similar to those
using the default 10% cut-off point for missing ADMS data (see sup-
plemental table S6).
4. Discussion
With inclusion of 219,486 births, including 5154 cases, this study is
one of the largest to examine the risk of congenital anomalies near
MWIs. Both modelled concentrations of PM10 from MWI emissions and
incinerator proximity were used as indicators of potential exposure to
pollution from MWIs. We found no increased risk of congenital
anomalies associated with modelled concentrations of PM10 but small
increases in risk across all congenital anomalies, CHDs and genital
anomalies with proximity to the nearest MWI. The limited correlation
between proximity to nearest MWI and modelled PM10 (Pearson cor-
relation=0·31) suggests that they are estimating different entities and
may at least partly explain the differing results for the two metrics.
4.1. Comparison with related studies
In line with our study findings, no previous studies have found as-
sociations of MWI emissions with all congenital anomalies combined or
all congenital anomalies excluding chromosomal anomalies. Dummer
et al. (2003) in their study examining congenital anomalies in relation to
four incinerators in a county of England in 1956–1993, found an asso-
ciation between proximity and lethal CHDs [OR: 1·12; 95% CI 1·03–1·22,
continuous odds ratio using the distance function 1/(D+0·1) where D is
the distance in km from the incinerator]. Similarly, in our study, we
found a 4% excess risk of CHDs (95% CI 1·01–1·08) for every 1 km closer
to an MWI when considering proximity to nearest MWI; however, there
was no association between severe CHDs and proximity to nearest MWI
Table 1
Characteristics of the study population.
Variable Totala
n (%)
All congenital anomalies
n (%)
All congenital anomalies excl. chromosomal
n (%)
Total n (%) 219,486 5154 (2·35%) 4172 (1·90%)
Sex n (%)
Male 112,650 (51·3%) 2800 (54·3%) 2315 (55·5%)
Female 106,573 (48·6%) 2093 (40·6%) 1615 (38·7%)
Indeterminate sex/unknown 263 (0·12%) 261 (5·06%) 242 (5·80%)
Maternal age n (%)
<20 years 18,830 (8·58%) 440 (8·54%) 395 (9·47%)
20–29 years (ref) 109,460 (49·9%) 2421 (47·0%) 2136 (51·2%)
30–39 years 84,644 (38·6%) 1978 (38·4%) 1502 (36·0%)
≥40 years 6552 (2·99%) 315 (6·11%) 139 (3·33%)
Percentage non-white ethnicityb n (%)
<5% 68,806 (31·3%) 1522 (29·5%) 1231 (29·5%)
5–14% 80,986 (36·9%) 1928 (37·4%) 1512 (36·2%)
15–30% 41,385 (18·9%) 919 (17·8%) 762 (18·3%)
>30% 28,309 (12·9%) 785 (15·2%) 667 (16·0%)
Year of birth n (%)
2003c 70 (0·039%) 55 (1·07%) 33 (0·791%)
2004 18,473 (8·42%) 459 (8·91%) 382 (9·15%)
2005 22,039 (10·0%) 591 (11·5%) 472 (11·3%)
2006 30,982 (14·1%) 771 (15·0%) 622 (14·9%)
2007 36,629 (16·7%) 907 (17·6%) 750 (18·0%)
2008 37,466 (17·1%) 857 (16·6%) 711 (17·0%)
2009 37,607 (17·1%) 837 (16·2%) 669 (16·0%)
2010 36,220 (16·5%) 677 (13·1%) 533 (12·8%)
Deprivation quintiled n (%)
1 - least deprived 25,124 (11·4%) 557 (10·9%) 395 (9·47%)
2 32,340 (14·7%) 740 (14·4%) 550 (13·2%)
3 38,153 (17·4%) 850 (16·5%) 663 (15·9%)
4 41,691 (19·0%) 995 (19·3%) 795 (19·1%)
5 - most deprived 82,178 (37·4%) 2052 (39·8%) 1769 (42·4%)
Mean major road length within 250m of maternal residence·
0m 116,490 (53·1%) 2677 (51·9%) 2147 (51·5%)
1–250m 12,168 (5·54%) 307 (5·96%) 255 (6·11%)
251–500m 59,688 (29·2%) 1372 (26·6%) 1125 (27·0%)
>500m 31,140 (14·2%) 798 (15·5%) 645 (15·5%)
Other sources of emissionse
<1 81,036 (36·9%) 1540 (29·9%) 1178 (28·2%)
1–2 82,322 (37·5%) 2274 (44·1%) 1872 (44·9%)
>2 56,128 (25·6%) 1340 (26·0%) 1122 (26·9%)
a Live births, stillbirths and TOPFAs, including congenital anomaly cases.
b Defined as % of non-white women aged 16–49 at the middle layer super output area (MSOA) level (2000 to 6000 households).
c Emission data for the MWIs was only available from the start of 2003, this means very few births in 2003 are included in the study because the 91 day pre-
pregnancy period would have started in 2002 for almost all 2003 births.
d Defined as the Carstairs deprivation quintile at the census output area (COA) level (40 to 250 households).
e Defined as number of industries divided by years of incinerator operation (see Table S3).
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[OR: 1·02; 95% CI 0·97–1·07] (Table 4b). While a previous study found a
link between CHDs and landfill sites (Elliott et al., 2009) causality has
been debated (COT, 2010).
All four previous studies investigating the risk of congenital
anomalies by modelling exposure from MWI emissions (Cordier et al.,
2004; Cordier et al., 2010; Vinceti et al., 2008; Vinceti et al., 2009;
Vinceti et al., 2018) used modelled maternal exposure to dioxins. Of
these, only the studies by Cordier et al. (2004, 2010) found evidence of
increased risk of some congenital anomalies subgroups (facial clefts,
renal dysplasia and urinary tract defects). We did not find excess of
these specific anomalies and modelled PM10 concentrations in our
study, although we did not model maternal exposure to dioxins.
No published study on MWIs to date has found associations with
genital anomalies and/or hypospadias. The aetiology of hypospadias is
largely unknown (van der Zanden et al., 2012); it has been suspected
that maternal exposure to endocrine disrupting chemicals is a risk
factor, but evidence is inconsistent (Ormond et al., 2009). Elevated risks
of hypospadias have been reported near landfill sites but may reflect
residual confounding (Elliott et al., 2009).
4.2. Strength and limitations
In this large retrospective cohort study we included all available live
birth, stillbirth, termination and congenital anomaly registration data
in the study area and period thus minimising selection bias (< 3.5%
exclusions). We used modelled PM10 concentrations as a means to in-
vestigate effects of MWI emissions, as well as proximity to a MWI. These
were based on postcode centroid of the mother's residence although not
the exact address, and do not account for migration during pregnancy
or paternal residence and exposure prior to the exposure period, all of
which may have led to misclassification bias (Hodgson et al., 2015).
The PM10 concentrations were modelled using a Gaussian dispersion
model treated deterministically rather than probabilistically, poten-
tially narrowing the confidence intervals for the analysis results.
Table 2
Distribution of PM10 exposure and distance to nearest MWI.
a) Distribution by exposure variables
Variable All birth recordsa
n (%)
All congenital anomalies
n (%)
All congenital anomalies excl. chromosomal
n (%)
Total n (%) 219,486 5154 (2·35) 4172 (1·90)
Distance to nearest MWI (km)b
<1 3464 (1·6) 104 (2·0) 86 (2·1)
≥1 to <2 12,256 (5·6) 289 (5·6) 228 (5·5)
≥2 to <3 21,101 (9·6) 538 (10·4) 451 (10·8)
≥3 to <4 31,644 (14·4) 784 (15·2) 627 (15·0)
≥4 to <5 28,906 (13·2) 730 (14·2) 612 (14·7)
≥5 to <6 31,554 (14·4) 773 (15·0) 623 (14·9)
≥6 to <7 29,531 (13·5) 626 (12·2) 511 (12·3)
≥7 to <8 22,680 (10·3) 500 (9·7) 394 (9·4)
≥8 to <9 20,352 (9·3) 420 (8·2) 342 (8·2)
≥9 to ≤10 17,998 (8·2) 390 (7·6) 298 (7·1)
Estimatedc PM10 distribution (10−3 μg/m3)
<0·00625 482 (0·2) 8 (0·2) 5 (0·1)
0·00625–0·0125 1644 (0·8) 29 (0·6) 25 (0·6)
0·0125–0·025 4361 (2·2) 115 (2·2) 92 (2·2)
0·025–0·05 9272 (4·4) 202 (3·9) 167 (4·0)
0·05–0·1 21,553 (9·8) 524 (10·2) 412 (9·88)
0·1–0·2 36,369 (16·6) 855 (16·6) 713 (17·1)
0·2–0·4 47,448 (21·6) 1059 (20·6) 855 (20·5)
0·4–0·8 45,819 (20·9) 1069 (20·8) 845 (20·2)
0·8–1·6 31,741 (14·9) 779 (15·1) 639 (15·3)
1·6–3·2 15,545 (7·1) 388 (7·5) 314 (7·5)
3·2–6·4 3924 (1·8) 103 (2·0) 90 (2·2)
≥6·4 873 (0·4) 23 (0·5) 17 (0·4)
b) Distribution by quantile
Variable All birth recordsa All congenital anomalies All congenital anomalies excl. chromosomal
Distance to nearest MWIb (km)
Minimum 0·12 0·36 0·36
1st quartile 3·57 3·45 3·43
Median 5·38 5·16 5·11
Mean 5·44 5·28 5·25
3rd quartile 7·23 7·05 6·98
Maximum 10·0 10·0 10·0
Estimatedc PM10 quartiles (10−3 μg/m3)
Minimum 0·00 5·30× 10−5 1·40×10−3
1st quartile 0·143 0·144 0·145
Median 0·339 0·348 0·348
Mean 0·643 0·666 0·670
3rd quartile 0·764 0·804 0·810
Maximum 20·4 15·7 15·7
a Live births, stillbirths and TOPFAs, including congenital anomaly cases.
b Proximity of the nearest MWI was calculated as a continuous measure of linear distance (km) from the postcode centroid of maternal residence at birth.
c Mean estimated PM10 concentration from ADMS dispersion modelling over 91 day pre-pregnancy period plus first trimester of pregnancy.
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Our models adjusted for other sources of pollution based on permits
to pollute in the vicinity of the MWI, and for road density which has
been shown to be a useful proxy for road traffic air pollution (Rose
et al., 2009), but these will not capture exposure to all local sources of
pollutants. We were reliant on modelling since we did not have in-
dividual-level measurements of exposures to MWI emissions for the
hundreds of thousands of mothers included in the study, nor would it be
feasible to collect such data. Use of a dispersion model assuming pri-
mary airborne exposure (as in our study) has been recommended to
reduce exposure misclassification (Cordioli et al., 2013). We found
statistically significant correlations between in-stack measurements of
PM10 and some heavy metals, polycyclic aromatic hydrocarbons and
polychlorinated biphenyls (Douglas et al., 2017; Ghosh et al., 2018), all
of which have previously been associated with risks of congenital
anomalies (Dolk and Vrijheid, 2003). However, based on limited
measurement data, we found weaker correlations between in-stack
measurements of PM10 and compounds of mercury or polychlorinated
dibenzo-p-dioxins and furans (PCDD/Fs) (Spearman's correlation values
of r=0·11–0·15) (Douglas et al., 2017; Ghosh et al., 2018), which have
been associated with increased risks of congenital anomalies (Dolk and
Vrijheid, 2003; van der Zanden et al., 2012), specifically with modelled
waste incinerator dioxin emissions (Cordier et al., 2010).
Distance is a cruder measure but may pick up other potentially toxic
emissions accumulating through non-airborne exposure pathways or
from local (non-stack) emissions. These might include, for example,
emissions from waste handling including waste transportation to the
MWI (estimated at 2% to 10% of MWI emissions in a hypothesised case
study by Ciuta et al., 2012), which may not be picked up by the stack
emissions modelling.
We found a weak correlation between proximity to nearest MWI and
both deprivation and ethnicity (table S4) and between all congenital
anomalies combined and proximity to nearest MWI; while we adjusted
at area level for deprivation and ethnicity, previously linked with in-
creased risks of CHD and hypospadias respectively (van der Zanden
et al., 2012; Varela et al., 2009), we did not have the relevant data to
adjust for these potential confounders at individual level, and it is
possible that association of proximity with these outcomes reflects re-
sidual confounding rather than ‘true’ (causal) effects.
Further considerations include the potential for bias in outcome
ascertainment and ambiguity of ICD10 coding, inconsistent reporting of
the severity of certain anomalies across registries and differences be-
tween English and Scottish datasets (e.g. lack of TOPFA data in the
Scottish data). Of particular relevance is the surveillance of hypospa-
dias cases which is known to be inconsistent with differences in as-
certainment between registries (Dolk et al., 2004). In 2004, Dolk et al.
suggested that the reporting systems in place were unlikely to provide
effective surveillance of hypospadias and notably these systems had not
changed during our study period.
5. Conclusions
This study found no increased risk of congenital anomalies in rela-
tion to mean modelled PM10 concentrations from MWIs in England and
Scotland as a proxy for MWI emissions more generally. Small increased
risks (2–7%) with proximity to the nearest MWI were observed for all
congenital anomalies combined, congenital heart defects and genital
anomalies, specifically hypospadias. These findings in proximity to
MWI might reflect residual confounding, although it is not possible
from these data to exclude a potential causal effect even in the absence
of associations with modelled PM10 emissions; further monitoring of
exposures and health outcomes near MWIs appears warranted.
Data
Births and deaths data were from the Office for National Statistics
(ONS) National Mortality, Births and Stillbirth register for England and
Wales and the National Health Service (NHS) Numbers for Babies
(NN4B). Scottish births and deaths were from the Information Services
Division (ISD) Scotland. TOPFAs were from the Department of Health
(now called Department of Health and Social Care).
English data on congenital anomalies are from the British and Irish
Network of Congenital Anomaly Researchers (BINOCAR) as well as
individual regional congenital anomaly registers (RCARs): Congenital
Anomaly Register for Oxfordshire, Berkshire and Buckinghamshire
(CAROBB); East Midlands & South Yorkshire Congenital Anomaly
Register (EMSYCAR); Northern Congenital Abnormality Survey
(NorCAS); South West Congenital Anomaly Register (SWCAR); Wessex
Antenatally Detected Anomalies Register (WANDA).
Incinerator emissions data came from the Environment Agency
(EA), and Scottish Environment Protection Agency (SEPA).
Data on industrial sites came from the Environment Agency
Environmental Permitting Regulations – Industrial sites (England), and
the Scottish Pollutant Release Inventory.
Road length data came from Meridian 2014 road lengths. Ordnance
Table 3
Risk of all congenital anomalies and all congenital anomalies without chromosomal congenital anomalies for modelled emissions and proximity to nearest MWI.
a.) Modelled emissions from nearest MWI
Outcome n cases/n totala Unadjusted ORb(95% CI) Fully adjustedc ORb (95% CI)
All congenital anomalies 5154/219,486 1·01 (1·00–1·03) 1·00 (0·98–1·02)
All congenital anomalies excl. chromosomal 4172/219,020 1·02 (1·00–1·03) 0·99 (0·97–1·01)
b.) Proximity to nearest MWI
Outcome n cases/n totala Unadjusted ORd (95% CI) Fully adjustedc ORd (95% CI)
All congenital anomalies 5154/219,486 1·03 (1·02–1·04) 1·02 (1·00–1·04)
All congenital anomalies excl. chromosomal 4172/219,020 1·04 (1·02–1·05) 1·02 (1·00–1·04)
Note: OR, odds ratio; CI, confidence interval. P-values for these results are reported in Table S11.
a Live births, stillbirths and TOPFAs, including congenital anomaly cases.
b Risk per doubling in modelled mean PM10 over exposure period. Modelled exposure to mothers (10−3 μgm−3): range 0–20·4, IQR 0·14–0·76, median 0·34, mean
0·64. Exposure is mean modelled PM10 concentration over 91 day pre-pregnancy period plus first trimester of pregnancy.
c Adjusted for maternal age, year of birth, area level ethnicity, area-level deprivation, other potential sources of emissions, MWI road density (length of mo-
torways, A-roads and B-roads within 10 km of the MWI), individual road density (length of motorways, A-roads and B-roads within 250m of mother's postcode);
random effect for MWI area and random slope for the exposure.
d Risk per km closer to nearest MWI (continuous).
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Survey data © Crown copyright and database right 2014.
CACI tobacco expenditure data is © Copyright 1996-2014 CACI
Limited. We attest that we have obtained appropriate permissions and
paid any required fees for use of copyright protected materials.
Data sharing
Health data are available from the data providers on application
with appropriate ethics and governance permissions, but we do not
hold data provider, ethics, or governance permissions to share the
health datasets with third parties.
Funding
The study was funded by a grant from Public Health England (PHE),
by a grant from the Scottish Government, funding from the MRC-PHE
Centre for Environment and Health and funding from the National
Institute for Health Research (NIHR) Health Protection Research Unit in
Health Impact of Environmental Hazards at King's College London and
Imperial College London in partnership with PHE (HPRU-2012-10141).
The UK Small Area Health Statistics Unit (SAHSU) is funded by PHE as
part of the MRC-PHE Centre for Environment and Health, funded also by
the UK Medical Research Council (MR/L01341X/1). PE is Director of the
Table 4
Risk of congenital anomaly outcomes by congenital anomalies grouping (chromosomal anomalies excluded) for modelled emissions and proximity to nearest MWI.
a.) Modelled exposure to PM10 from nearest MWI
n cases/n totala Unadjusted ORb (95% CI) Fully adjustedc ORb (95% CI)
Congenital anomaly groups
Nervous system 543/215,863 1·02 (0·97–1·07) 0·97 (0·92–1·02)
Congenital heart defects 1232/216,644 1·08 (1·05–1·12) 0·99 (0·93–1·05)
Abdominal wall defects 222/215,788 0·99 (0·93–1·07) 1·00 (0·92–1·08)
Oro-facial clefts 339/215,931 1·04 (0·98–1·10) 1·00 (0·94–1·07)
Limb defects 746/216,252 0·92 (0·89–0·96) 1·01 (0·94–1·08)
Digestive system 355/215,928 1·04 (0·98–1·10) 1·00 (0·92–1·09)
Urinary system 534/216,037 1·03 (0·98–1·08) 1·00 (0·94–1·07)
Genital system 472/216,053 0·96 (0·92–1·01) 1·03 (0·95–1·13)
Congenital anomaly sub-groups
Neural tube defects 264/215,695 1·04 (0·97–1·11) 1·00 (0·92–1·07)
Severe congenital heart defects 436/215,954 1·07 (1·02–1·13) 1·03 (0·97–1·10)
Gastroschisis 133/215,753 1·04 (0·95–1·15) 1·04 (0·94–1·15)
Cleft palate 124/215,749 1·03 (0·94–1·14) 1·02 (0·92–1·13)
Cleft lip with or without cleft palate 217/215,822 1·04 (0·96–1·12) 1·00 (0·93–1·08)
Limb reduction defects 122/215,725 1·04 (0·94–1·15) 1·02 (0·91–1·14)
Oesophageal atresia 51/215,681 1·07 (0·92–1·25) 1·04 (0·88–1·22)
Anomalies of the renal system 241/215,803 1·04 (0·97–1·12) 1·02 (0·95–1·10)
Obstructive defects of renal pelvis 255/215,840 0·97 (0·91–1·04) 0·97 (0·90–1·04)
Hypospadias 407/216,004 0·96 (0·91–1·01) 1·00 (0·90–1·12)
b.) Proximity to nearest MWI
n cases/n totala Unadjusted ORd
(95% CI)
Fully Adjustedc ORd
(95% CI)
Congenital anomaly groups
Nervous system 543/215,863 1·02 (0·98–1·05) 0·97 (0·93–1·02)
Congenital heart defects 1232/216,644 1·04 (1·01–1·06) 1·04 (1·01–1·08)
Abdominal wall defects 222/215,788 0·97 (0·92–1·03) 1·00 (0·94–1·07)
Oro-facial clefts 339/215,931 0·99 (0·95–1·04) 0·99 (0·94–1·05)
Limb defects 746/216,252 1·06 (1·03–1·09) 1·02 (0·97–1·08)
Digestive system 355/215,928 0·98 (0·93–1·02) 1·00 (0·95–1·06)
Urinary system 534/216,037 1·02 (0·98–1·06) 1·02 (0·97–1·06)
Genital system 472/216,053 1·10 (1·06–1·15) 1·07 (1·02–1·12)
Congenital anomaly sub-groups
Neural tube defects 264/215,695 1·00 (0·95–1·05) 0·97 (0·91–1·03)
Severe congenital heart defects 436/215,954 1·02 (0·98–1·07) 1·02 (0·97–1·07)
Gastroschisis 133/215,753 0·95 (0·88–1·02) 0·97 (0·89–1·05)
Cleft palate 124/215,749 0·96 (0·89–1·03) 0·98 (0·90–1·06)
Cleft lip with or without cleft palate 217/215,822 1·01 (0·95–1·07) 1·00 (0·94–1·07)
Limb reduction defects 122/215,725 1·04 (0·96–1·12) 0·98 (0·90–1·08)
Oesophageal atresia 51/215,681 0·95 (0·85–1·07) 0·92 (0·80–1·05
Anomalies of the renal system 241/215,803 1·00 (0·95–1·05) 1·00 (0·93–1·07)
Obstructive defects of renal pelvis 255/215,840 1·04 (0·99–1·10) 1·03 (0·97–1·10
Hypospadias 407/216,004 1·11 (1·07–1·16) 1·07 (1·01–1·12)
Note: OR, odds ratio; CI, confidence interval. P-values and P-values after Simes procedure adjustment for multiple testing for these results are reported in Table S12.
a Live births, stillbirths and TOPFAs, including congenital anomaly cases.
b Risk per doubling in modelled mean PM10 over exposure period. Modelled exposure to mothers (10−3 μgm−3): range 0–20·4, IQR 0·14–0·76, median 0·34, mean
0·64. Exposure is mean modelled PM10 concentration over 91 day pre-pregnancy period plus first trimester of pregnancy.
c Adjusted for maternal age, year of birth, area level ethnicity, area-level deprivation, other potential sources of emissions, MWI road density (length of mo-
torways, A-roads and B-roads within 10 km of the MWI), individual road density (length of motorways, A-roads and B-roads within 250m of mother's postcode);
random effect for MWI area and random slope for the exposure.
d Risk per km closer to nearest MWI (continuous).
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